Chimerix Inc is categorized under Commercial Medical Research in Durham, NC and active since 2000.
Chimerix Inc was established in 2000, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Kenneth Moch, Chief Executive Officer at the company’s headquarters by writing to 2505 Meridian Parkway # 340, Durham, North Carolina NC 27713 or by phoning (919) 806-1074. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chimerix Inc |
| Contact Person: | Kenneth Moch, Chief Executive Officer |
| Address: | 2505 Meridian Parkway # 340, Durham, North Carolina 27713 |
| Phone Number: | (919) 806-1074 |
| Website Address: | chimerix.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2000 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 3254120 |
| Share This Business: |
Chimerix Inc was started in 2000 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Kenneth Moch, Chief Executive Officer for inquiries that concern Chimerix Inc by calling the company number (919) 806-1074, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Chimerix Inc can be found at the coordinates 35.910819,-78.894826 as well as the street address 2505 Meridian Parkway # 340 in Durham, North Carolina 27713.
For its online presence, you may visit Chimerix Inc’s website at chimerix.com and engage with its social media outlets through on Twitter and on Facebook.